Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Standard of Care × 30 days × Clear all

Sponsor

Conditions

Neoplasms 5 Lung Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Myelodysplastic Syndromes 2 Hematologic Neoplasms 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Tobacco Use 1 Teratoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Skin Carcinoma 1 Sarcopenia 1 Sarcoglycanopathies 1 Renal Insufficiency, Chronic 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Opioid-Related Disorders 1

Interventions

Cyclophosphamide 10 fludarabine 8 Rituximab 8 obinutuzumab 7 Prednisone 6 Lenalidomide 6 tocilizumab 5 ibrutinib 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 polatuzumab vedotin 3 X-Rays 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 Vincristine 2 Vemurafenib 2 Trastuzumab 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡